Ampio Pharmaceuticals (AMPE) Competitors $0.0027 -0.13 (-97.93%) As of 06/11/2025 01:54 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock AMPE vs. BPTSY, NCNA, MYMD, KRBP, VRPX, CAPS, TFFP, BON, TCBP, and VINCShould you be buying Ampio Pharmaceuticals stock or one of its competitors? The main competitors of Ampio Pharmaceuticals include Biophytis (BPTSY), NuCana (NCNA), MyMD Pharmaceuticals (MYMD), Kiromic BioPharma (KRBP), Virpax Pharmaceuticals (VRPX), Capstone (CAPS), TFF Pharmaceuticals (TFFP), Bon Natural Life (BON), TC Biopharm (TCBP), and Vincerx Pharma (VINC). These companies are all part of the "pharmaceutical products" industry. Ampio Pharmaceuticals vs. Its Competitors Biophytis NuCana MyMD Pharmaceuticals Kiromic BioPharma Virpax Pharmaceuticals Capstone TFF Pharmaceuticals Bon Natural Life TC Biopharm Vincerx Pharma Ampio Pharmaceuticals (NYSE:AMPE) and Biophytis (NASDAQ:BPTSY) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, community ranking, media sentiment, institutional ownership, profitability and dividends. Do institutionals & insiders hold more shares of AMPE or BPTSY? 5.7% of Ampio Pharmaceuticals shares are held by institutional investors. Comparatively, 0.1% of Biophytis shares are held by institutional investors. 3.3% of Ampio Pharmaceuticals shares are held by insiders. Comparatively, 3.7% of Biophytis shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has more volatility and risk, AMPE or BPTSY? Ampio Pharmaceuticals has a beta of 4.92, suggesting that its share price is 392% more volatile than the S&P 500. Comparatively, Biophytis has a beta of 0.85, suggesting that its share price is 15% less volatile than the S&P 500. Which has stronger valuation & earnings, AMPE or BPTSY? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmpio PharmaceuticalsN/AN/A-$8.63M-$11.010.00BiophytisN/AN/A-$18.43MN/AN/A Is AMPE or BPTSY more profitable? Company Net Margins Return on Equity Return on Assets Ampio PharmaceuticalsN/A N/A N/A Biophytis N/A N/A N/A Does the MarketBeat Community believe in AMPE or BPTSY? Ampio Pharmaceuticals and Biophytis both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformAmpio PharmaceuticalsOutperform VotesNo VotesUnderperform Votes78100.00% BiophytisN/AN/A Does the media favor AMPE or BPTSY? In the previous week, Biophytis had 1 more articles in the media than Ampio Pharmaceuticals. MarketBeat recorded 1 mentions for Biophytis and 0 mentions for Ampio Pharmaceuticals. Ampio Pharmaceuticals' average media sentiment score of 0.00 beat Biophytis' score of -1.00 indicating that Ampio Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment Ampio Pharmaceuticals Neutral Biophytis Negative SummaryAmpio Pharmaceuticals beats Biophytis on 4 of the 6 factors compared between the two stocks. Get Ampio Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMPE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AMPE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AMPE vs. The Competition Export to ExcelMetricAmpio PharmaceuticalsPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$3K$6.85B$5.57B$19.81BDividend YieldN/A2.55%5.28%3.83%P/E Ratio0.008.7827.1435.68Price / SalesN/A255.49419.3246.74Price / CashN/A65.8538.2517.52Price / Book0.006.557.064.84Net Income-$8.63M$143.93M$3.23B$1.02B7 Day PerformanceN/A3.84%2.83%1.94%1 Month PerformanceN/A11.20%9.02%3.03%1 Year PerformanceN/A4.18%31.36%9.73% Ampio Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AMPEAmpio Pharmaceuticals0.2964 of 5 stars$0.00-97.9%N/A-97.9%$3KN/A0.0020BPTSYBiophytisN/A$1.38-20.2%N/A-82.2%$484KN/A0.0030Short Interest ↑Gap DownNCNANuCana3.5363 of 5 stars$0.08+52.7%$25.00+32,708.4%-94.6%$433KN/A-0.0130High Trading VolumeMYMDMyMD PharmaceuticalsN/A$0.17+5.3%N/A-90.9%$398KN/A0.006Gap DownHigh Trading VolumeKRBPKiromic BioPharmaN/AN/AN/AN/A$330KN/A-0.0660Gap DownHigh Trading VolumeVRPXVirpax Pharmaceuticals1.5631 of 5 stars$0.24-1.8%$75.00+31,150.0%-98.5%$298KN/A0.007Gap UpCAPSCapstoneN/A$1.88+1.1%N/AN/A$297K$43.42M0.0038Gap UpTFFPTFF PharmaceuticalsN/A$0.07flatN/AN/A$289K-$70.98K-0.0119BONBon Natural LifeN/A$1.72+4.2%N/AN/A$287K$23.84M0.00100Short Interest ↑Gap UpTCBPTC Biopharm1.5147 of 5 stars$0.68-55.8%$48.00+6,948.5%-99.6%$279K$4.76M0.0080News CoverageHigh Trading VolumeVINCVincerx Pharma3.6136 of 5 stars$0.05-9.5%$40.00+77,419.4%-99.7%$270KN/A0.0060Short Interest ↓ Related Companies and Tools Related Companies Biophytis Competitors NuCana Competitors MyMD Pharmaceuticals Competitors Kiromic BioPharma Competitors Virpax Pharmaceuticals Competitors Capstone Competitors TFF Pharmaceuticals Competitors Bon Natural Life Competitors TC Biopharm Competitors Vincerx Pharma Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:AMPE) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ampio Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ampio Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AMPE Stock Free AMPE Stock Alerts